Physician profile
Ankit A Patel
NPI 1801089842
$17,433.33
in general payments reported to CMS, 2019-2025
40 companies · $699 in 2025
The $699 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,294 · 2020: $1,804 · 2021: $1,282 · 2022: $2,648 · 2023: $8,055 · 2024: $650 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Food and Beverage: $2,287 · Consulting Fee: $500 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Food and Beverage | $2,287.20 |
| Consulting Fee | $500.00 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $6,920.07 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $2,218.77 | 2019-2025 | Xact, Portico, Amplatzer |
| Cardiovascular Systems INC. | $1,757.03 | 2019-2023 | Diamondback Peripheral |
| Medtronic Vascular, INC. | $1,233.42 | 2019-2020 | |
| Medtronic, INC. | $666.58 | 2021-2025 | Symplicity G3, Resolute Onyx |
| Abiomed | $544.77 | 2020-2025 | Impella |
| Cordis US Corp. | $512.31 | 2022-2023 | Brite Tip Radianz |
| Boston Scientific Corporation | $357.76 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $299.79 | 2021-2024 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $284.60 | 2019-2025 | |
| Edwards Lifesciences Corporation | $260.27 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Amgen INC. | $255.04 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $229.00 | 2022-2023 | Acticor 7 Vr-T Dx |
| Asahi Intecc USA, INC. | $191.81 | 2022 | |
| Pfizer INC. | $168.96 | 2019-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.